Hyperbilirubinemia in Atazanavir Treated HIV-infected Patients: The Impact of the UGT1A1*28 Allele

Pharmacogenomics and Personalized Medicine - New Zealand
doi 10.2147/pgpm.s107152
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

High Prevalence of the UGT1A1*28 Variant in HIV-infected Individuals in Greece

International Journal of STD and AIDS
PharmacologyPublic HealthEnvironmentalDermatologyInfectious DiseasesOccupational Health
2014English

External Validation of the Bilirubin–Atazanavir Nomogram for Assessment of Atazanavir Plasma Exposure in HIV-1-Infected Patients

AAPS Journal
Pharmaceutical Science
2012English

Impact of UGT1A1 Polymorphisms on Raltegravir and Its Glucuronide Plasma Concentrations in a Cohort of HIV-1 Infected Patients

Scientific Reports
Multidisciplinary
2018English

Safety of Darunavir and Atazanavir in HIV-infected Children in Europe and Thailand

Antiviral Therapy
Infectious DiseasesPharmacology
2015English

Short Communication: Aging Not Gender Is Associated With High Atazanavir Plasma Concentrations in Asian HIV-Infected Patients

AIDS Research and Human Retroviruses
VirologyInfectious DiseasesImmunology
2013English

The Impact of Buprenorphine/Naloxone Treatment on HIV Risk Behaviors Among HIV-infected, Opioid-Dependent Patients

Drug and Alcohol Dependence
PsychiatryToxicologyMental HealthPharmacology
2014English

Characteristics and Outcomes of Antiretroviral-Treated HIV-HBV Co-Infected Patients in Canada?

BMC Infectious Diseases
Infectious Diseases
2019English

Switching to Unboosted Atazanavir Improves Glucose Tolerance in Highly Pretreated HIV-1 Infected Subjects

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2007English

Demodecosis in Hiv-Infected Patients

Meditsinskaya Parazitologiya i Parazitarnye Bolezni
MedicineParasitology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy